Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Thelwell

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Seminars in Thrombosis and Hemostasis|February 1, 2014
Biological standards for potency assignment to fibrinolytic agents used in thrombolytic therapyCraig Thelwell
FEBS Letters|June 10, 2005
Understanding the enzymology of fibrinolysis and improving thrombolytic therapyColin Longstaff, Craig Thelwell
Plos One|January 27, 2017
Activity Regulation by Fibrinogen and Fibrin of Streptokinase from Streptococcus PyogenesSian Huish, Craig Thelwell, Colin Longstaff
Nature Biotechnology|April 9, 2005
Regulatory frameworks in developing countriesColin Longstaff, Craig Thelwell, Colin Whitton
Journal of Thrombosis and Haemostasis : JTH|February 8, 2019
Establishment of the WHO 2nd International Standard Factor V, plasma (16/374): communication from the SSC of the ISTHAnthony R Hubbard, Craig Thelwell, Peter Rigsby, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2019
A new WHO reference reagent for activated blood coagulation factor X (FXa), human (15/102)Craig Thelwell, John Hogwood, Sarah Daniels, et al.
Analytical Biochemistry|October 13, 2021
Quantitation of thrombin-activatable fibrinolysis inhibitor in human plasma by isotope dilution mass spectrometryJun X Wheeler, Craig Thelwell, Peter Rigsby, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 19, 2013
Differential scanning fluorimetry: rapid screening of formulations that promote the stability of reference preparationsKiran Malik, Paul Matejtschuk, Craig Thelwell, et al.
Blood Vessels, Thrombosis & Hemostasis|October 13, 2025
M1 protein from group A <i>Streptococcus</i> affects fibrin clot formation, structure, and fibrinolytic potentialSophie Cherrington, Lewis J Hardy, Azhar Maqbool, et al.
Thrombosis Research|February 7, 2018
Endothelial cell functions impaired by interferon in vitro: Insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapyHaiyan Jia, Craig Thelwell, Paula Dilger, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Seminars in Thrombosis and Hemostasis|February 1, 2014
Biological standards for potency assignment to fibrinolytic agents used in thrombolytic therapyCraig Thelwell
FEBS Letters|June 10, 2005
Understanding the enzymology of fibrinolysis and improving thrombolytic therapyColin Longstaff, Craig Thelwell
Plos One|January 27, 2017
Activity Regulation by Fibrinogen and Fibrin of Streptokinase from Streptococcus PyogenesSian Huish, Craig Thelwell, Colin Longstaff
Nature Biotechnology|April 9, 2005
Regulatory frameworks in developing countriesColin Longstaff, Craig Thelwell, Colin Whitton
Journal of Thrombosis and Haemostasis : JTH|February 8, 2019
Establishment of the WHO 2nd International Standard Factor V, plasma (16/374): communication from the SSC of the ISTHAnthony R Hubbard, Craig Thelwell, Peter Rigsby, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2019
A new WHO reference reagent for activated blood coagulation factor X (FXa), human (15/102)Craig Thelwell, John Hogwood, Sarah Daniels, et al.
Analytical Biochemistry|October 13, 2021
Quantitation of thrombin-activatable fibrinolysis inhibitor in human plasma by isotope dilution mass spectrometryJun X Wheeler, Craig Thelwell, Peter Rigsby, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 19, 2013
Differential scanning fluorimetry: rapid screening of formulations that promote the stability of reference preparationsKiran Malik, Paul Matejtschuk, Craig Thelwell, et al.
Blood Vessels, Thrombosis & Hemostasis|October 13, 2025
M1 protein from group A <i>Streptococcus</i> affects fibrin clot formation, structure, and fibrinolytic potentialSophie Cherrington, Lewis J Hardy, Azhar Maqbool, et al.
Thrombosis Research|February 7, 2018
Endothelial cell functions impaired by interferon in vitro: Insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapyHaiyan Jia, Craig Thelwell, Paula Dilger, et al.
Pageof 2